Ketchum Steven B

CIK 00012898843 companiesBEDMINSTER, NJ

SEC Profile

Transactions

Companies

Filings

CIK

0001289884

Recent Transactions

24 trades

Exercise/Conversion
AMARIN CORP PLC\UK$AMRN
Ordinary Shares
2018-12-31$2.50/sh+4,167→ 348,068 total
Exercise/Conversion
AMARIN CORP PLC\UK$AMRN
Ordinary Shares
2018-12-31$1.40/sh+2,604→ 343,901 total
Exercise/Conversion
AMARIN CORP PLC\UK$AMRN
Ordinary Shares
2018-12-31$2.95/sh+2,770→ 358,338 total
Exercise/Conversion
AMARIN CORP PLC\UK$AMRN
Ordinary Shares
2018-12-31$2.50/sh+3,750→ 355,568 total
Exercise/Conversion
AMARIN CORP PLC\UK$AMRN
Stock Option (Right to Buy)
2018-12-31−3,750→ 52,938 total
Exercise/Conversion
AMARIN CORP PLC\UK$AMRN
Stock Option (Right to Buy)
2018-12-31−3,750→ 22,500 total
Exercise/Conversion
AMARIN CORP PLC\UK$AMRN
Ordinary Shares
2018-12-31$2.50/sh+3,750→ 351,818 total
Exercise/Conversion
AMARIN CORP PLC\UK$AMRN
Stock Option (Right to Buy)
2018-12-31−2,770→ 69,770 total
Exercise/Conversion
AMARIN CORP PLC\UK$AMRN
Stock Option (Right to Buy)
2018-12-31−4,167→ 24,998 total
Exercise/Conversion
AMARIN CORP PLC\UK$AMRN
Stock Option (Right to Buy)
2018-12-31−2,604→ 33,854 total
Sale
AMARIN CORP PLC\UK$AMRN
Ordinary Shares
2018-12-31$13.51/sh−17,041→ 341,297 total
Award
Viracta Therapeutics, Inc.$VIRX
Stock Option (Right to Buy)
2014-06-30+20,000→ 20,000 total
Award
Viracta Therapeutics, Inc.$VIRX
Stock Option (Right to Buy)
2014-06-30+20,000→ 20,000 total
Award
AMARIN CORP PLC\UK$AMRN
Stock Option (right to buy)
2013-01-02+33,750→ 33,750 total
Award
Viracta Therapeutics, Inc.$VIRX
Stock Option (Right to Buy)
2011-06-30+450,000→ 450,000 total
Award
Viracta Therapeutics, Inc.$VIRX
Stock Option (Right to Buy)
2011-06-30+450,000→ 450,000 total
Conversion
Viracta Therapeutics, Inc.$VIRX
Common Stock
2010-06-30+99,940→ 340,535 total
Purchase
Viracta Therapeutics, Inc.$VIRX
Common Stock
2010-06-30$0.28/sh+238,243→ 240,595 total
Conversion
Viracta Therapeutics, Inc.$VIRX
Series A Preferred Stock
2010-06-30−9,994→ 0 total
Purchase
Viracta Therapeutics, Inc.$VIRX
Common Stock
2010-06-30$0.28/sh+238,243→ 240,595 total
Conversion
Viracta Therapeutics, Inc.$VIRX
Common Stock
2010-06-30+99,940→ 340,535 total
Conversion
Viracta Therapeutics, Inc.$VIRX
Series A Preferred Stock
2010-06-30−9,994→ 0 total
Award
Viracta Therapeutics, Inc.$VIRX
Stock Option (Right to Buy)
2009-08-31+450,000→ 450,000 total
Award
Viracta Therapeutics, Inc.$VIRX
Stock Option (Right to Buy)
2009-08-31+450,000→ 450,000 total

Companies

Recent Filings

Address

C/O AMARIN PHARMA, INC. 1430 ROUTE 206

BEDMINSTER, NJ, 07921

View on SEC.gov